Elanco Animal Health (ELAN) Tops Q1 EPS by 1c; Guides Q2 Lower
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Elanco Animal Health Reports First Quarter 2022 Results
May 9, 2022 6:30 AM EDTFirst Quarter 2022 Financial Results Revenue of $1,225 million Reported Net Income of $48 million, Adjusted Net Income of $177 million Adjusted EBITDA of $339 million or 27.7% of Revenue Reported EPS of $0.10, Adjusted EPS of $0.36 Updating full year 2022 revenue guidance to be $4,700 to $4,755 million, due to the negative impact of foreign exchange rates; constant currency revenue growth guidance remains unchanged. Increasing guidance for full year 2022 diluted EPS to $0.02 to $0.09 on a reported basis and updating... More
